반응식
O[C:2]1([C:26]2[C:27]([OH:35])=[CH:28][C:29]3[O:33][CH2:32][CH2:31][C:30]=3[CH:34]=2)[C:10]2[CH:9]=[C:8]3[O:11][CH2:12][CH2:13][O:14][C:7]3=[CH:6][C:5]=2[N:4]([CH2:15][C:16]2[O:17][C:18]([C:21]([F:24])([F:23])[F:22])=[CH:19][CH:20]=2)[C:3]1=[O:25].C([SiH](CC)CC)C.FC(F)(F)C(O)=O>ClCCl>[OH:35][C:27]1[C:26]([CH:2]2[C:10]3[CH:9]=[C:8]4[O:11][CH2:12][CH2:13][O:14][C:7]4=[CH:6][C:5]=3[N:4]([CH2:15][C:16]3[O:17][C:18]([C:21]([F:24])([F:23])[F:22])=[CH:19][CH:20]=3)[C:3]2=[O:25])=[CH:34][C:30]2[CH2:31][CH2:32][O:33][C:29]=2[CH:28]=1참가 물질
5
반응물 3
생성물 1
시약·촉매·용매 1
실험 절차
To a solution of 8-hydroxy-8-(6-hydroxy-2,3-dihydrobenzofuran-5-yl)-6-((5-(trifluoromethyl)furan-2-yl)methyl)-6,8-dihydro-2H-[1,4]dioxino[2,3-f]indol-7(3H)-one (1.81 g, 3.70 mmol) in dichloromethane (50 mL) were added triethylsilane (6.0 mL) and trifluoroacetic acid (10 mL) at 0° C. The resultant mixture was stirred at 0° C. for 2 h and concentrated in vacuo to dryness to afford 8-(6-hydroxy-2,3-dihydro-1-benzofuran-5-yl)-6-{[5-(trifluoromethyl)furan-2-yl]methyl}-2,3,6,8-tetrahydro-7H-[1,4]dioxino[2,3-f]indol-7-one (1.70 g, 97%): MS (ES+) m/z 473.9 (M+1).
후처리
- concentrationconcentrated in vacuo to dryness
출처 및 근거
- ORD 기록
- ord-69173cc2a1244f1c91e596ea4d8a2fac
- 출처 데이터셋
- uspto-grants-2013_04
- 특허 번호
- US08415370B2
연결된 노트
불러오는 중…